Journal
JOURNAL OF MATERIALS CHEMISTRY B
Volume 4, Issue 2, Pages 188-197Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c5tb01332a
Keywords
-
Categories
Funding
- Howard Hughes Medical Institute (HHMI)
- Department of Defense/Air Force Office of Scientific Research [FA95501310192, FA9550-11-1-0275]
- National Institutes of Health/National Cancer Institute [U54CA151880, R01CA167041]
- Dixon Translational Grants Initiative through North-western University Clinical and Translational Sciences Institute
Ask authors/readers for more resources
High-density lipoproteins (HDL) are a class of natural nanostructures found in the blood and are composed of lipids, proteins, and nucleic acids (e.g. microRNA). Their size, which appears to be well-suited for both tissue penetration/retention as well as payload delivery, long circulation half-life, avoidance of endosomal sequestration, and potential low toxicity are all excellent properties to model in a drug delivery vehicle. In this review, we consider high-density lipoproteins for therapeutic delivery systems. First we discuss the structure and function of natural HDL, describing in detail its biogenesis and transformation from immature, discoidal forms, to more mature, spherical forms. Next we consider features of HDL making them suitable vehicles for drug delivery. We then describe the use of natural HDL, discoidal HDL analogs, and spherical HDL analogs to deliver various classes of drugs, including small molecules, lipids, and oligonucleotides. We briefly consider the notion that the drug delivery vehicles themselves are therapeutic, constituting entities that exhibit theralivery.'' Finally, we discuss challenges and future directions in the field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available